77 related articles for article (PubMed ID: 15341195)
21. Recent clinical failures in Parkinson's disease with apoptosis inhibitors underline the need for a paradigm shift in drug discovery for neurodegenerative diseases.
Waldmeier P; Bozyczko-Coyne D; Williams M; Vaught JL
Biochem Pharmacol; 2006 Nov; 72(10):1197-206. PubMed ID: 16901468
[TBL] [Abstract][Full Text] [Related]
22. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
Hol EM; Fischer DF; Ovaa H; Scheper W
Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
[TBL] [Abstract][Full Text] [Related]
23. Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures.
Tian YY; An LJ; Jiang L; Duan YL; Chen J; Jiang B
Life Sci; 2006 Dec; 80(3):193-9. PubMed ID: 17049947
[TBL] [Abstract][Full Text] [Related]
24. Nicotine neuroprotection against nigrostriatal damage: importance of the animal model.
Quik M; O'Neill M; Perez XA
Trends Pharmacol Sci; 2007 May; 28(5):229-35. PubMed ID: 17412429
[TBL] [Abstract][Full Text] [Related]
25. An in vitro model of inflammatory neurodegeneration and its neuroprotection.
Messmer K; Reynolds GP
Neurosci Lett; 2005 Nov; 388(1):39-44. PubMed ID: 16102901
[TBL] [Abstract][Full Text] [Related]
26. Riluzole, unlike the AMPA antagonist RPR119990, reduces motor impairment and partially prevents motoneuron death in the wobbler mouse, a model of neurodegenerative disease.
Fumagalli E; Bigini P; Barbera S; De Paola M; Mennini T
Exp Neurol; 2006 Mar; 198(1):114-28. PubMed ID: 16386734
[TBL] [Abstract][Full Text] [Related]
27. Implication of PTEN in production of reactive oxygen species and neuronal death in in vitro models of stroke and Parkinson's disease.
Zhu Y; Hoell P; Ahlemeyer B; Sure U; Bertalanffy H; Krieglstein J
Neurochem Int; 2007 Feb; 50(3):507-16. PubMed ID: 17169462
[TBL] [Abstract][Full Text] [Related]
28. Iminium metabolite mechanism for nicotine toxicity and addiction: Oxidative stress and electron transfer.
Kovacic P; Cooksy A
Med Hypotheses; 2005; 64(1):104-11. PubMed ID: 15533623
[TBL] [Abstract][Full Text] [Related]
29. Acetaminophen attenuates dopamine neuron degeneration in animal models of Parkinson's disease.
Locke CJ; Fox SA; Caldwell GA; Caldwell KA
Neurosci Lett; 2008 Jul; 439(2):129-33. PubMed ID: 18514411
[TBL] [Abstract][Full Text] [Related]
30. Drosophila: a "model" model system to study neurodegeneration.
Celotto AM; Palladino MJ
Mol Interv; 2005 Oct; 5(5):292-303. PubMed ID: 16249525
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death?
Sullivan PG; Rabchevsky AG; Waldmeier PC; Springer JE
J Neurosci Res; 2005 Jan 1-15; 79(1-2):231-9. PubMed ID: 15573402
[TBL] [Abstract][Full Text] [Related]
32. Neuroimmunophilins: a novel drug therapy for the reversal of neurodegenerative disease?
Poulter MO; Payne KB; Steiner JP
Neuroscience; 2004; 128(1):1-6. PubMed ID: 15450348
[TBL] [Abstract][Full Text] [Related]
33. Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-alpha-lipoic acid.
Cui X; Zuo P; Zhang Q; Li X; Hu Y; Long J; Packer L; Liu J
J Neurosci Res; 2006 Jun; 83(8):1584-90. PubMed ID: 16555301
[TBL] [Abstract][Full Text] [Related]
34. Taurine fails to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion in mice.
Navneet AK; Appukuttan TA; Pandey M; Mohanakumar KP
Amino Acids; 2008 Aug; 35(2):457-61. PubMed ID: 17701098
[TBL] [Abstract][Full Text] [Related]
35. The adult human brain in preclinical drug development.
Dragunow M
Nat Rev Drug Discov; 2008 Aug; 7(8):659-66. PubMed ID: 18617887
[TBL] [Abstract][Full Text] [Related]
36. Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease.
Ryu JK; Choi HB; McLarnon JG
Neuroscience; 2006 Sep; 141(4):1835-48. PubMed ID: 16809003
[TBL] [Abstract][Full Text] [Related]
37. Protective effects of SUN N8075, a novel agent with antioxidant properties, in in vitro and in vivo models of Parkinson's disease.
Oyagi A; Oida Y; Hara H; Izuta H; Shimazawa M; Matsunaga N; Adachi T; Hara H
Brain Res; 2008 Jun; 1214():169-76. PubMed ID: 18457816
[TBL] [Abstract][Full Text] [Related]
38. Cell death assays for neurodegenerative disease drug discovery.
Linsley JW; Reisine T; Finkbeiner S
Expert Opin Drug Discov; 2019 Sep; 14(9):901-913. PubMed ID: 31179783
[No Abstract] [Full Text] [Related]
39. The propulsive administration of nicotine as a new approach for capturing and restraining cattle.
HAYES FA; JENKINS JH; FEURT SD; CROCKFORD JA
J Am Vet Med Assoc; 1959 Mar; 134(6):283-6. PubMed ID: 13641087
[No Abstract] [Full Text] [Related]
40. A nuclease inhibitor for neurodegeneration.
Eccleston A
Nat Rev Drug Discov; 2022 Jul; 21(7):493. PubMed ID: 35650422
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
